Search

everythinglearnresearchcommunity

for

Search:↓

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Men with baldness, ear creases, and hairy ears have a higher risk of heart disease.

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

Many men misuse oral contraceptive pills for things like hair growth and muscle gain.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Vitiligo is underreported in medical claims and is linked to certain skin types and autoimmune diseases.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Vasodilators may worsen abdominal aortic aneurysm.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Severe and early hair loss may indicate a higher risk of heart disease.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

Higher homocysteine levels may inhibit hair growth and are linked to androgenetic alopecia.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

About one-third of Saudi women with female pattern hair loss also have thinning hair at the back of their head.

Alopecia areata significantly impacts patients' mental health and quality of life.

Being overweight can cause or worsen skin problems in children, some more common in darker skin, and is often linked to insulin resistance.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Spironolactone might lower the chance of getting rosacea.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Men with male pattern baldness have increased arterial stiffness.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.